A GRANDAD who has found a new lease of life after having a kidney transplant is taking on a 135-mile bike ride as a thank you to the hospitals that cared for him.
Skin transplant surgery safe and effective for patients with vitligo – News-Medical.net
Skin transplant surgery safe and effective for patients with vitligoNews-Medical.netHenry Ford Hospital dermatologists say skin transplant surgery is safe and effective for restoring skin pigmentation caused by the skin disease vitligo. In a first stud…
Single Center Data From C-Pulse(R) Feasibility Trial in Patients With Moderate … – MarketWatch (press release)
Single Center Data From C-Pulse(R) Feasibility Trial in Patients With Moderate …MarketWatch (press release)SYDNEY, AUSTRALIA and EDEN PRAIRIE, MN, May 31, 2012 (MARKETWIRE via COMTEX) — Sunshine Heart, Inc. (NASDAQ:SSH) (asx:SHC), a global medical d…
Heart transplant recipient sets Half Iron Man as next physical test
Kyle Garlett is no longer held back by the fear of taking his body to physical extremes. Early on as a heart transplant recipient, Garlett was hesitant to push himself beyond a certain limit when not knowing how much his body could withstand during phy…
Omahan made transplant history
Terri Sempek made medical history in Nebraska on March 27, 1991, when she was the first person to have a pancreas transplant at the Nebraska Medical Center.
UCLA Debuts Face Transplantation Program (Medgadget Interview) – Medgadget.com
Medgadget.comUCLA Debuts Face Transplantation Program (Medgadget Interview)Medgadget.comThe patient must agree to follow a drug schedule to prevent transplant rejection and attend all appointments at the transplant center. recipient donor face transpla…
Cell Therapeutics' Pixuvri® Phase 3 Clinical Trial Results Published in The … – Equities.com
Cell Therapeutics' Pixuvri® Phase 3 Clinical Trial Results Published in The …Equities.comThe EMA's Committee for Medicinal Products for Human Use ("CHMP") has accepted PIX306, CTI's ongoing randomized controlled phase 3 clinica…
Cell Therapeutics' Pixuvri® Phase 3 Clinical Trial Results Published in The … – MarketWatch (press release)
Cell Therapeutics' Pixuvri® Phase 3 Clinical Trial Results Published in The …MarketWatch (press release)The EMA's Committee for Medicinal Products for Human Use ("CHMP") has accepted PIX306, CTI's ongoing randomized controlled …
Cell Therapeutics' Pixuvri® Phase 3 Clinical Trial Results Published in The Lancet Oncology
SEATTLE , May 31, 2012 /PRNewswire/ — Cell Therapeutics, Inc.("CTI") (Nasdaq and MTA: CTIC) today announced that results from its PIX301 phase 3 clinical trial of Pixuvri® (pixantrone) have …
Novartis showcases ongoing research at ASCO to help patients fight various … – MarketWatch (press release)
OncLiveNovartis showcases ongoing research at ASCO to help patients fight various …MarketWatch (press release)An 18-month analysis from the Phase III BOLERO-2 study (Breast cancer trials of OraL EveROlimus) (abstract #559; June 2, 8:00AM – 12:00PM) c…